News and Trends 6 Dec 2022Positive results from BioAge muscle atrophy trial BioAge Labs, Inc. has announced positive phase 1b clinical data for BGE-105, a highly selective, potent, orally available small-molecule agonist… December 6, 2022 - 4 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email